3A). promotes tumor growth of HCC by focusing on PTEN-mediated PI3K/AKT pathway, and potentially serves as a book prognostic biomarker and therapeutic target to get HCC. Keywords: microRNA-519a, hepatocellular carcinoma, phosphatase and tensin homolog, PI3K/AKT signaling, tumor growth == Introduction == Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and the third leading causes of cancer-related death (1, 2). Despite recent advances in clinical and experimental treatment, the prognosis of HCC remains poor with a dismal 5-year survival (3), and the comprehensive mechanism underlying the development and progression of HCC has not been fully elucidated (4). Therefore , it is of great importance to clarify the molecular mechanisms of HCC and develop novel strategies for the diagnosis and treatment of HCC. MicroRNAs (miRNAs) are endogenous non-coding 2022 nucleotide RNAs that regulate protein expression by interacting with complementary sites within the 3-untranslated region (UTR) of target mRNAs (57). Increasing evidence suggests that aberrant expression of miRNAs plays crucial roles in various cellular processes, including cell proliferation, apoptosis, differentiation, migration and invasion (813). In addition , GNE-8505 it has been widely recognized that deregulation of miRNAs may lead to abnormal expression of oncogenes or tumor suppressors and contribute to the development and progression of human cancers. miR-519a, which belongs to a big cluster of miRNAs, C19MC, plays a critical role in the pathogenesis of GNE-8505 human cancers. It played an oncogenic role and could serve as a diagnostic and prognostic biomarker in ovarian epithelial tumors (14). Moreover, it was recently found to confer tamoxifen resistance by targeting the phosphatase and tensin homolog (PTEN), retinoblastoma protein (RB1), and cyclin-dependent kinase inhibitor 1A (CDKN1A)/p21 in estrogen receptor (ER)+breast cancer (15). Studies have shown that miR-519a functioned as a tumor suppressor through multiple p21-inducing pathways in HeLa human cervical carcinoma (16). Moreover, miR-519a reduced cell proliferation by lowering RNA-binding protein HuR levels in colon carcinoma (17). Thus, the exact roles of miR-519a in human being cancers are cancer-type specific. However , the Ankrd11 functional role of miR-519a and the underlying mechanisms in HCC are still unknown. In this study, we demonstrated that upregulation of miR-519a was associated with poor prognostic features and reduced 5-year survival of HCC patients. Gain- and loss-of-function studies revealed that miR-519a promoted HCC cell proliferation and cell cycle progression. Finally, we identified PTEN and PI3K/AKT pathway because direct focuses on of miR-519a. == Components and methods == == Clinical tissues and data == Tumor samples and matched tumor-adjacent tissues were obtained from 116 patients undergoing curative resection of their primary HCC in the Department of Hepatobiliary Surgical treatment at the 1st Affiliated Hospital of Xi’an Jiaotong University during January 2006 to December 2009. Clinical sample was used after obtaining knowledgeable consent from each patient. None from the patients GNE-8505 had received any perioperative chemo- or radiotherapy. The demographic and clinicopathological data of all enrolled patients were obtained through review of hospital information, and are presented inTable I. The protocols of this study were approved by the Xi’an Jiaotong University Ethics Committee according to the Declaration of Helsinki. == Table I. GNE-8505 == Correlation between the clinicopathological characteristics and miR-519a expression in HCC (n=116). HCC, hepatocellular GNE-8505 carcinoma; HBV, hepatitis W virus; AFP, -fetoprotein; TNM, tumor-node-metastasis. Statistically significant. == Cell culture and treatment == The human immortalized regular hepatic cell line LO2 and HCC.